Newleos Therapeutics Secures $93.5M Series A to Advance CNS Drug Development
Key Highlights Newleos Therapeutics secures $93.5 million in Series A funding, led by Goldman Sachs Alternatives, with participation from Novo Holdings A/S,…
Browsing Tag
Goldman Sachs Alternatives
1 post